User profiles for Tom Fletcher
 | Tom FletcherUniversity of Bath Verified email at bath.ac.uk Cited by 506 |
[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …
was announced, containing far more mutations in Spike (S) than previously reported …
[HTML][HTML] Clinical features and management of human monkeypox: a retrospective observational study in the UK
…, CJA Duncan, J Dunning, TE Fletcher… - The Lancet Infectious …, 2022 - thelancet.com
Background Cases of human monkeypox are rarely seen outside of west and central Africa.
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …
There are few data regarding viral kinetics or the duration of viral shedding and no licensed …
[HTML][HTML] A minimal common outcome measure set for COVID-19 clinical research
Clinical research is necessary for an effective response to an emerging infectious disease
outbreak. However, research efforts are often hastily organised and done using various …
outbreak. However, research efforts are often hastily organised and done using various …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
…, GS Cooke, A da Silva Filipe, T Fletcher… - The Lancet …, 2021 - thelancet.com
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
[HTML][HTML] Clinical presentation of patients with Ebola virus disease in Conakry, Guinea
EI Bah, MC Lamah, T Fletcher, ST Jacob… - … England Journal of …, 2015 - Mass Medical Soc
Background In March 2014, the World Health Organization was notified of an outbreak of
Zaire ebolavirus in a remote area of Guinea. The outbreak then spread to the capital, Conakry, …
Zaire ebolavirus in a remote area of Guinea. The outbreak then spread to the capital, Conakry, …
[HTML][HTML] Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
…, GS Cooke, A da Silva Filipe, T Fletcher… - The Lancet …, 2021 - thelancet.com
Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …
cases are urgently required to inform clinical management decisions. Methods We …
[HTML][HTML] Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective …
Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…
complications. These complications are likely to have important short-term and long-…
Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
…, T Kredo, M Chaplin, T Fletcher - Cochrane Database …, 2021 - cochranelibrary.com
Background The coronavirus disease 2019 (COVID‐19) pandemic has resulted in substantial
mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine (HCQ) for …
mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine (HCQ) for …
[HTML][HTML] Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort …
…, GS Cooke, A da Filipe, T Fletcher… - The Lancet …, 2021 - thelancet.com
Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …
[HTML][HTML] An Energy Management Strategy to concurrently optimise fuel consumption & PEM fuel cell lifetime in a hybrid vehicle
T Fletcher, R Thring, M Watkinson - international journal of hydrogen …, 2016 - Elsevier
The cost and reliability of fuel cells are major obstructions preventing fuel cell hybrid electric
vehicle (FCHEV) from entering the mainstream market. However, many of the degradation …
vehicle (FCHEV) from entering the mainstream market. However, many of the degradation …